The latest announcement is out from DocMorris ( (CH:DOCM) ).
DocMorris AG has announced a significant capital increase of CHF 200 million to support its growth strategy, particularly in the prescription drug segment, which saw a 52.3% increase in sales in the first quarter of 2025. The company aims to achieve sustainable growth with a focus on profitability, targeting an EBITDA breakeven by 2026 and positive free cash flow by 2027, while continuing to expand its TeleClinic services and marketplace offerings.
More about DocMorris
DocMorris AG is a prominent player in the online pharmacy, marketplace, and professional healthcare sectors, with significant operations in Germany and other European countries. The company operates a highly automated logistics center in the Netherlands and leads the marketplace for health and care products in Southern Europe. With a vision of creating a digital health ecosystem, DocMorris serves over 10 million active customers and is listed on the SIX Swiss Exchange.
YTD Price Performance: -6.26%
Average Trading Volume: 129,999
Technical Sentiment Signal: Strong Buy
Current Market Cap: CHF236.5M
Learn more about DOCM stock on TipRanks’ Stock Analysis page.